2019

25/07/2019 Revenue at 30 June 2019

Revenue of €400.6 million for the 1st half of the year, in line with annual targets: • +2.8% at current exchange rates• +1.8% at constant exchange rates Villepinte, 25 July 2019 – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, today...

[more]


16/07/2019


26/06/2019 ET 2019: Guerbet to participate at the European Conference on Embolotherapy

ET 2019 │ Booth No. 4 │ from June 26th to 29th │ Valencia Conference Centre│ Valencia (Spain) Guerbet will be a diamond sponsor at the ET 2019 (European Conference on Embolotherapy) conference that will be held from June 26 to June 29 in Valencia. Our team will be present and warmly invite...

[more]


25/06/2019 MLCTO 2019: Once again, Guerbet partners in the initiatives implemented for interventional cardiologists

Guerbet will participate in the fourth edition of the MLCTO (Multi-Level Chronic Total Occlusion) course as Diamond sponsor, from June 27 to 29th in Nice, France at Palais de la Méditerranée. The event supports all the initiatives implemented for interventional cardiologists in their CTO PCI...

[more]


21/06/2019 Guerbet a partner of the first HTID edition

Guerbet is proud to support the 1st HTID (Health Tech Investors Day) event from 24th to 25th June 2019 at Peninsula Paris organized by France Biotech. For the first time, the European Life Sciences community is organizing a two-day event. It will feature thematic panel discussions and...

[more]


12/06/2019 Guerbet strengthens its commitment to Women’s Health

• The company will attend the 2019 RCOG World Conference in London & ESHRE Annual Meeting in Vienna • Guerbet also highlights the value of Hysterosalpingography (HSG) in Infertility Management Villepinte (France), June 12, 2019 - Guerbet (FR0000032526 GBT), a global specialist...

[more]


05/06/2019 New indication approved for Guerbet’s Lipiodol® Ultra Fluid

Lipiodol® Ultra Fluid now approved for conventional trans-arterial chemoembolization of intermediate-stage hepatocellular carcinoma in Switzerland and in India

[more]


Displaying results 1 to 7 out of 16
<< First < Previous 1-7 8-14 15-16 Next > Last >>